(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Lung cancer is one of the biggest challenges in oncology today. The challenge is due to the recognition of the possibility of prevention in at least 70-80 % of all the cases and the extreme difficulties encountered in the treatment of this neoplasm. Despite the knowledge of prevention measures such as cessation of cigarette smoking the incidence continues to increase in many countries. The increase is particularly notable in females in the west ernized countries where the death rate in females in certain regions sur passes that of breast cancer. Furthermore, in many developing countries lung cancer is now being diagnosed with increasing frequency in both sexes and it is expected to be a major cause of death in those countries later in this century or the beginning of next century if the tobacco consumption will continue its rapid rise. With respect to therapy the 1970'es brought considerable progress in understanding of the clinical behaviour of lung cancer thereby establishing the importance of distinguishing between the major histologic types. Thera peutic advancement was particularly experienced in small cell carcinoma with the introduction of combination chemotherapy after this special dis ease entity among lung cancers was recognized as being a disseminated dis ease in almost all cases at the time of diagnosis. It was expected that the improvement in therapy would have continued in the early 1980'es, not only for small cell lung cancer but also for the other cell types.
Contents:
1. Immunohistology in the Classification of Lung Cancer.- 2. The Use of Monoclonal Antibodies for the Pathological Diagnosis of Lung Cancer.- 3. In Vitro Characterization of Non-Small Cell Lung Cancer.- 4. Clinical Correlates of Biological Studies of Small Cell Lung Cancer.- 5. Limitations and Potentials of In Vitro Sensitivity Testing of Human Small Cell Carcinoma of the Lung.- 6. Screening for Lung Cancer: Recent Experience in the United States.- 7. Peptide Hormones in Small Cell Lung Cancer: Their Usefulness for Diagnosis, Staging and Monitoring of Treatment.- 8. Prognostic Factors in Small Cell Lung Cancer: An Analysis of 874 Consecutive Patients.- 9. Diagnostic Procedures in the Detection of CNS Metastases from Small Cell Lung Cancer.- 10. CT-Scanning in the Pre-Operative Assessment of Non-Small Cell Lung Cancer.- 11. Radiosensitizers and Lung Cancer: Basic and Clinical Aspects.- 12. Effects of Photodynamic Therapy in Lung Cancer with Particular Reference to Early Stage Cases.- 13. High-Dose Chemotherapy for Small Cell Lung Cancer.- 14. Therapy of Lung Cancer - Any Progress? An Overview of the Last Decade.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag New York Inc.)
Publication date: October, 2011
Pages: 274
Weight: 444g
Availability: Available
Subcategories: Oncology
From the same series
